ZYME
ZYME
NASDAQ · Biotechnology

Zymeworks Inc

$24.02
+0.70 (+3.00%)
As of Mar 23, 10:02 PM ET ·
Financial Highlights (FY 2026)
Revenue
106.17M
Net Income
-81,283,875
Gross Margin
Profit Margin
-76.6%
Rev Growth
-36.4%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 42.5% 42.5%
Operating Margin -87.3% -78.6% 19.5% 17.9%
Profit Margin -76.6% -72.7% 15.6% 18.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 106.17M 167.01M 182.20M 158.08M
Gross Profit 77.45M 67.20M
Operating Income -92,728,818 -131,281,950 35.58M 28.36M
Net Income -81,283,875 -115,078,633 28.41M 28.63M
Gross Margin 42.5% 42.5%
Operating Margin -87.3% -78.6% 19.5% 17.9%
Profit Margin -76.6% -72.7% 15.6% 18.1%
Rev Growth -36.4% -36.4% +8.1% +23.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 595.07M 530.52M
Total Equity 1.01B 987.85M
D/E Ratio 0.59 0.54
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -88,997,495 -132,999,245 52.86M 47.86M
Free Cash Flow 21.80M 16.91M